Neurocrine Biosciences Inc (NASDAQ:NBIX)

38.78
Delayed Data
As of Mar 27
 +1.45 / +3.88%
Today’s Change
12.17
Today|||52-Week Range
45.36
+73.59%
Year-to-Date
No recent news for Neurocrine Biosciences Inc.

Today’s Trading

Previous close37.33
Today’s open37.40
Day’s range37.40 - 39.23
Volume1,056,974
Average volume (3 months)1,323,498
Market cap$3.3B
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)-17.39%
Earnings growth (this year)-27.29%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book14.21

Competitors

 Today’s
change
Today’s
% change
IPXLImpax Laboratories I...+0.87+1.94%
ACADACADIA Pharmaceutica...+1.59+5.24%
HZNPHorizon Pharma PLC+0.69+3.27%
WXWuxi Pharmatech Caym...+0.36+0.97%
Data as of 4:03pm ET, 03/27/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$0.30
Annual revenue (last year)$0.00
Annual profit (last year)-$60.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin Charles Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account